Fund Name | Location |
China Bridge Capital | Beijing, Beijing, China |
CMC XXI | - |
Columbia Pacific Advisors | Seattle, United States, Washington |
D.R. Horton | Fort Worth, Texas, United States |
Family Venture Capital | England, London, United Kingdom |
FreeBit Co, Ltd | Chiyoda, Japan |
Hyperdrive SEO Agency | - |
Launchpad Digital Health | California, San Francisco, United States |
LaunchYU | Canada, Ontario, Toronto |
New Generation Media | China, Haikou, Hainan |
Ombu Group | England, London, United Kingdom |
Palio Portfolio Ltd | Switzerland, Zurich, Zurich |
Red Apple Group | New York, New York, United States |
SBRI Healthcare | Cambridge, Cambridgeshire, United Kingdom |
Steve Walker and Associates | England, London, United Kingdom |
Synchrony Ventures | California, San Francisco, United States |
Theravance Biopharma | California, South San Francisco, United States |
Tokai University | Chiyoda, Japan |
Waycross Ventures | California, Menlo Park, United States |
Yiyili Technology | China, Guangdong, Shenzhen |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.